Tirzepatide, a recently approved medication, is sparking significant excitement in the scientific community as a viable treatment for both diabetes, type 2 and weight loss . This dual-action drug works by targeting two different receptors, GLP-1 and GIP, leading to enhanced glycemic management and substantial fat loss in testing. While initial data